Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.48 |
| ▸ | CNR1 | P21554 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ACAT1 | P24752 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14761903 | 0.94 | CNR1 (0.41) | CNR2CNR1CYP17A1ALDH1A1 | |
| SCHEMBL14762264 | 0.90 | ALDH1A1 (0.48) | KDM4ECYP17A1ALDH1A1 | |
| SCHEMBL8756075 | 0.81 | CNR2 (0.45) | CNR2CNR1KDM4ETP53CYP3A4 | |
| SCHEMBL9080244 | 0.80 | KDM4E (0.48) | CNR2CNR1KDM4ETP53CYP3A4 | |
| SCHEMBL9420901 | 0.74 | CYP1A2 (0.52) | KDM4ETSHRCYP17A1 | |
| SCHEMBL19148406 | 0.74 | AOC3 (0.59) | MAPTALOX15ALDH1A1 | |
| SCHEMBL17295895 | 0.74 | AOC3 (0.59) | MAPTALOX15ALDH1A1 | |
| SCHEMBL10656156 | 0.74 | KDM4E (0.46) | KDM4EMAPTTSHR | |
| SCHEMBL20313083 | 0.73 | CNR2 (0.46) | CNR2CNR1KDM4ETP53CYP3A4 | |
| SCHEMBL15355750 | 0.73 | CNR2 (0.46) | CNR2CNR1KDM4ETP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9911927-B2 | Compounds having semiconducting properties and related compositions and devices | FLEXTERRA, INC. (US) | 2018-03-06 | — | — | US | disclosed |
| US-20160351832-A1 | Compounds Having Semiconducting Properties and Related Compositions and Devices | USINVEST LLC | 2016-12-01 | — | — | US | disclosed |
| US-20130062598-A1 | Compounds Having Semiconducting Properties and Related Compositions and Devices | POLYERA CORPORATION | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130062598-A1 | Compounds Having Semiconducting Properties and Related Compositions and Devices | NES, KCNN2, MYB | CNR2 3238/4885CNR1 3388/4885KDM4E 3136/4885 |
| US-20160351832-A1 | Compounds Having Semiconducting Properties and Related Compositions and Devices | NES, KCNN2, MYB | CNR2 3238/4885CNR1 3388/4885KDM4E 3136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.